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We thank Dr Dodge-Khatami for
his interest and insightful questions.
Because the methods of inducing
catch-up growth of the hypoplastic
ventricles and valves in patients with
unbalanced atrioventricular canal
(UAVC) defects are not yet standard
procedures, the technical details are
of considerable importance.
There are also several important
general points about these operations
that should ease the concern about
embarking on this approach.
The general principle is to increase
flow across the hypoplastic atrioven-
tricular (AV) valve, which generates
the ventricular growth signal and in-
duces catch-up growth of the hypo-
plastic ventricles and valves.1 Even
the smallest of these structures have
enormous growth potential, and with
the growth conditions met, the hypo-
plastic valves and ventricles will catch
up surprisingly quickly.
While catch-up growth is occur-
ring, septal defects are left behind to
allow intracardiac shunting that will
maintain adequate systemic and pul-
monary blood flows. After the first
stage, the patients predictably will beThe Journalstable because of the intracardiac
shunting. There is no need to ‘‘bite
the bullet’’ in an all-or-nothing opera-
tion and hope that a complete repair
will be tolerated.
A restrictive atrial septal defect
(ASD) is used to both allow shunting
and increase flow across the hypoplas-
tic AV valve to generate the growth
signal. In right ventricle (RV)–domi-
nant UAVC defects, a ventricular sep-
tal defect (VSD) is also left behind so
that the RV can augment left ventricu-
lar (LV) flow and maintain an ade-
quate cardiac output (CO).1
The AV valve repair itself is helpful
whether the end result is a 2-ventricle
or single-ventricle repair. AUAVC le-
sion is a known risk factor for a Fontan
procedure, at least in part because of
AV valve problems, and valve repair
should reduce this risk.
Finally, these growth-inducing op-
erations do not irreversibly commit
patients to a 2-ventricle repair, and
a single-ventricle track remains avail-
able if necessary.
The following is in regard to your
specific questions:
1. The partial VSD repair: A VSD is
left behind only in RV-dominant
UAVC defects where the CO must
be augmented by the RV.1 A com-
plete VSD patch closure is done
first in the usual fashion for a 2-
patch AV canal defect repair,
which stabilizes the valves. It also
allows the upper edge of the patch
to be placed away from the hypo-
plastic component when dividing
the common AV valve leaflet, so
it will enlarge the area of the hypo-
plastic valve.2
2. The residual VSD is created by cut-
ting a hole in the center of the VSD
patch. The hole must be big enough
to allow augmentation of LVoutput,
so it depends on the size of the pa-
tient. The size is not exact, but it
should be at least 5 mm in diameter.
The hole should not be so big, how-
ever, that it discourages transmitral
flow.Thesepatientswill havepulmo-of Thoracic and Cardiovascular Surgenary artery bands, so the pulmonary
vasculature will be protected.
When growth is adequate, the hole
in the patch can be closed surgi-
cally. Because the septal rim of
the VSD is patched, there will
not be a risk of heart block dur-
ing closure of the hole.
In an LV-dominant UAVC lesion,
augmentation through a residual
VSD is usually not necessary.
Only approximately half a CO
will provide sufficient pulmo-
nary blood flow, and if more is
needed, a shunt can be placed
to allow time for the RV to
grow. These patients do require
a restrictive ASD to encourage
tricuspid flow and contribute to
the CO by right-to-left shunting.
3. Limits to the degree of hypoplasia in
the growth ofUAVC defects: No pa-
tients have been turned down, even
with a ventricular z score of less
than 7 or a rudimentary mitral
valve. The hypoplastic valves and
ventricles will reliably grow. We all
grow 20- to 30-fold after birth, so
a lot of potential growth is available.
Our article illustrates a tiny mitral
valve, which would have been
highlyobstructiveafteracomplete
repair. To provide adequate mitral
flow, the large tricuspid valvewas
split in 2, which left the patient
with 2 mitral valves. As shown,
the tiny mitral valve grew well
and reached normal size.2
Most of the hypoplastic AV valves in
our series were only small, but
a fewwerealsodeformed.Among
the deformities repaired were
a 2-layer mitral valve and several
with significant regurgitation.
Mostarerepairable,but ifnot,a re-
placed mitral valve in a 2-ventri-
cle repair should still be better
than a single ventricle repair, es-
pecially one with bad AV valves.
4. Snared ASD: The reason for keep-
ing the ASD snare mechanism sep-
arate from the primum ASD patch
is that the snare is adjusted offry c Volume 144, Number 3 741
Letters to the Editorbypass and will pull on the patch
and perhaps on the AV valves, pos-
sibly making them leak. There is
usually some atrial septum avail-
able, but if not, I would put the
hole and snare as far lateral as pos-
sible, which should make the pull
on the rest of the repair negligible.
John E. Foker, MD, PhD
on behalf of all authors
Division of Cardiothoracic Surgery
University of Minnesota
Minneapolis, Minn
References
1. Foker JE, Berry JM, Steinberger J. Ventricular
growth stimulation to achieve two-ventricle repair
in unbalanced common atrioventricular canal.
Prog Pediatr Cardiol. 1999;10:173-86.
2. Foker JE, Berry JM, Harvey BA, Pyles LA. Mitral
and tricuspid valve repair and growth in unbalanced
atrial ventricular canal defects. J Thorac Cardio-
vasc Surg. 2012;143:S29-32.
http://dx.doi.org/10.1016/
j.jtcvs.2012.06.015WILL LOCAL USE OF
ANTIBIOTICS BE ESSENTIAL?
To the Editor:
We appreciate the study by Schim-
mer and colleagues1 on gentamicin-
collagen sponge use for heart surgery.
They demonstrated a reduction of
wound complication after surgery by
gentamicin-collagen sponge use.
We agree with Schimmer and col-
leagues1 and strongly recommend
applying antibiotics directly to the
surgical site. Our previous study was
on the prevention of surgical site in-
fection by antibiotic spraying.2 We
used not only gentamicin but also ce-
fazolin. In our study, the incidence of
deep surgical site infection was
0.50% in 2612 patients. We chose
gentamicin and cefazolin because
they cover the most likely contami-
nants, such as Staphylococcus aureus
and Pseudomonas aeruginosa. In the
study by Schimmer and colleagues,1
S aureus cases were low despite the
use of only gentamicin.
Local use of antibiotics is not ac-
cepted by guidelines for prevention of742 The Journal of Thoracic and Csurgical site infection3 because there
is no strong evidence. The references
of the guidelines did not report better
results thanSchimmer and colleagues.1
In reality, many surgeons apply an-
tibiotics by local spraying or subcuta-
neous injection. We think local use of
antibiotics is an essential method for
postoperative reduction of wound
complications.
Hiroshi Osawa, MD, PhD
Kouan Orii, MD, PhD
Division of Cardiothoracic Surgery
Shimada General Hospital
Chiba, Japan
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We appreciate the kind comments1
on our publication ‘‘Gentamicin-Col-
lagen Sponge Reduces Sternal Wound
Complications After Heart Surgery: A
Controlled, Prospectively Random-
ized, Double-Blind Study’’2 regarding
our results of the routine prophylactic
retrosternal use of a gentamicin-
collagen sponge in patients undergo-
ing cardiac surgery. Our answers to
the 3 points included in the letter to
the Editor are as follows:
1. The most likely contaminants of
deep sternal wound infections
(mediastinitis) in our study were
coagulase-negative staphylococci
(68.4%), gram-negative bacteria
(10.5%), Propionibacterium acnes
(10.5%), and Staphylococcus
aureus (5.3%).2 This microbialardiovascular Surgery c September 201spectrum is similar to that in the
Swedish study by Friberg and col-
leagues,3 in which coagulase-
negative staphylococci formed the
largest group of pathogens. The
number of S aureus cases ac-
counted for 2.4% (1 case) in the
presented study, 21.7% in a Swed-
ish study, and 37.3% in a US
study.4 In our study and the Swed-
ish study, there were no patients
with methicillin-resistant S aureus.
By contrast, methicillin-resistant
S aureus infection was identified
in 10.2% of the microbial isolates
(27.3% of the S aureus cases) in
the US study. The extent to which
the dissimilar microbial spectra
and possible antibiotic resistance
influence the results cannot be
clarified.
2. The guidelines for prevention of
surgical site infections investigating
intraoperative gentamicin implant
before wound closure involve 2
randomized controlled trials.3,5,6
Figure 1 shows that the 2 studies
were combined in a meta-analysis,
and that a statistically significant
difference was found favoring the
gentamicin implant (odds ratio,
0.49; 95% confidence interval,
0.34-0.68; I2 ¼ 0%).6
Engelmann and colleagues7 sum-
marized these 2 studies in 2007
by observing that a slight reduc-
tion in infection was seen, but
the population was too small to
draw a definitive conclusion.
Although the use of topical
antibiotics is controversial, and
they are not used by most car-
diac surgeons, the existing
studies demonstrate a reduction
in the wound infection rate.
More study is warranted
before topical antibiotics can
be recommended as a standard
prophylaxis.7 Our study is a ran-
domized controlled trial and
therefore fulfils this demand
and is a contribution toward
more evidence in the prevention
of surgical site infection.2
